Burden of illness in Parkinson's disease
Identifieur interne : 003997 ( Main/Exploration ); précédent : 003996; suivant : 003998Burden of illness in Parkinson's disease
Auteurs : Daniel M. Huse [États-Unis] ; Kathy Schulman [États-Unis] ; Lucinda Orsini [États-Unis] ; Jane Castelli-Haley [États-Unis] ; Sean Kennedy [États-Unis] ; Gregory Lenhart [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2005-11.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Child, Child, Preschool, Cohort Studies, Confidence Intervals, Cost of Illness, Costs, Databases, Factual (statistics & numerical data), Female, Health Care Costs, Humans, Infant, Male, Middle Aged, Nervous system diseases, Parkinson Disease (economics), Parkinson Disease (epidemiology), Parkinson disease, Parkinson's disease, Prevalence, Retrospective Studies, Sex Factors, cost of illness, health economics, resource use.
- MESH :
- economics : Parkinson Disease.
- epidemiology : Parkinson Disease.
- statistics & numerical data : Databases, Factual.
- Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Child, Child, Preschool, Cohort Studies, Confidence Intervals, Cost of Illness, Female, Health Care Costs, Humans, Infant, Male, Middle Aged, Prevalence, Retrospective Studies, Sex Factors.
Abstract
This study quantifies direct medical care costs for individual patients with Parkinson's disease (PD) and projects total national costs of PD. Anonymous, patient‐level data on health care utilization and cost were obtained from Medstat's MarketScan Research Databases. Patients were selected for study if they had either two instances of a diagnosis of PD or one diagnosis and two or more prescriptions for PD‐related medication. A control group of persons without PD was selected for comparison. Total annual health care utilization and costs were calculated for both PD patients and controls. A total of 20,016 patients with PD were identified and followed up for an average of 853 days. The mean age of the patients was 73.6 years, and 51.2% were women. Total annual direct costs were $23,101 (SD 27,529) per patient with PD versus $11,247 (SD 16,486) for controls. The regression‐adjusted incremental direct cost of PD versus control was $10,349 (95% confidence interval, 9,053, 11,645). Adding $25,326 in indirect costs, and multiplying by 645,000 cases of PD in the United States, the total cost to the nation is projected to be $23 billion annually. This estimate is higher than most previous studies, with important implications for health care delivery systems worldwide. © 2005 Movement Disorder Society
Url:
DOI: 10.1002/mds.20609
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001857
- to stream Istex, to step Curation: 001857
- to stream Istex, to step Checkpoint: 002407
- to stream PubMed, to step Corpus: 002F85
- to stream PubMed, to step Curation: 002F85
- to stream PubMed, to step Checkpoint: 003210
- to stream Ncbi, to step Merge: 001327
- to stream Ncbi, to step Curation: 001327
- to stream Ncbi, to step Checkpoint: 001327
- to stream Main, to step Merge: 005084
- to stream PascalFrancis, to step Corpus: 001D10
- to stream PascalFrancis, to step Curation: 001011
- to stream PascalFrancis, to step Checkpoint: 001F15
- to stream Main, to step Merge: 005393
- to stream Main, to step Curation: 003997
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Burden of illness in Parkinson's disease</title><author><name sortKey="Huse, Daniel M" sort="Huse, Daniel M" uniqKey="Huse D" first="Daniel M." last="Huse">Daniel M. Huse</name></author><author><name sortKey="Schulman, Kathy" sort="Schulman, Kathy" uniqKey="Schulman K" first="Kathy" last="Schulman">Kathy Schulman</name></author><author><name sortKey="Orsini, Lucinda" sort="Orsini, Lucinda" uniqKey="Orsini L" first="Lucinda" last="Orsini">Lucinda Orsini</name></author><author><name sortKey="Castelli Aley, Jane" sort="Castelli Aley, Jane" uniqKey="Castelli Aley J" first="Jane" last="Castelli-Haley">Jane Castelli-Haley</name></author><author><name sortKey="Kennedy, Sean" sort="Kennedy, Sean" uniqKey="Kennedy S" first="Sean" last="Kennedy">Sean Kennedy</name></author><author><name sortKey="Lenhart, Gregory" sort="Lenhart, Gregory" uniqKey="Lenhart G" first="Gregory" last="Lenhart">Gregory Lenhart</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:D5F4BC3C405F04FCE02FD174DC18799BEDFB75ED</idno><date when="2005" year="2005">2005</date><idno type="doi">10.1002/mds.20609</idno><idno type="url">https://api.istex.fr/document/D5F4BC3C405F04FCE02FD174DC18799BEDFB75ED/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001857</idno><idno type="wicri:Area/Istex/Curation">001857</idno><idno type="wicri:Area/Istex/Checkpoint">002407</idno><idno type="wicri:doubleKey">0885-3185:2005:Huse D:burden:of:illness</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:16007641</idno><idno type="wicri:Area/PubMed/Corpus">002F85</idno><idno type="wicri:Area/PubMed/Curation">002F85</idno><idno type="wicri:Area/PubMed/Checkpoint">003210</idno><idno type="wicri:Area/Ncbi/Merge">001327</idno><idno type="wicri:Area/Ncbi/Curation">001327</idno><idno type="wicri:Area/Ncbi/Checkpoint">001327</idno><idno type="wicri:doubleKey">0885-3185:2005:Huse D:burden:of:illness</idno><idno type="wicri:Area/Main/Merge">005084</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:06-0077736</idno><idno type="wicri:Area/PascalFrancis/Corpus">001D10</idno><idno type="wicri:Area/PascalFrancis/Curation">001011</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">001F15</idno><idno type="wicri:doubleKey">0885-3185:2005:Huse D:burden:of:illness</idno><idno type="wicri:Area/Main/Merge">005393</idno><idno type="wicri:Area/Main/Curation">003997</idno><idno type="wicri:Area/Main/Exploration">003997</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Burden of illness in Parkinson's disease</title><author><name sortKey="Huse, Daniel M" sort="Huse, Daniel M" uniqKey="Huse D" first="Daniel M." last="Huse">Daniel M. Huse</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Thomson Medstat, Cambridge, Massachusetts</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Schulman, Kathy" sort="Schulman, Kathy" uniqKey="Schulman K" first="Kathy" last="Schulman">Kathy Schulman</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Thomson Medstat, Cambridge, Massachusetts</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Orsini, Lucinda" sort="Orsini, Lucinda" uniqKey="Orsini L" first="Lucinda" last="Orsini">Lucinda Orsini</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Thomson Medstat, Cambridge, Massachusetts</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Castelli Aley, Jane" sort="Castelli Aley, Jane" uniqKey="Castelli Aley J" first="Jane" last="Castelli-Haley">Jane Castelli-Haley</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Teva Neuroscience, Kansas City, Missouri</wicri:regionArea><placeName><region type="state">Missouri (État)</region></placeName></affiliation></author><author><name sortKey="Kennedy, Sean" sort="Kennedy, Sean" uniqKey="Kennedy S" first="Sean" last="Kennedy">Sean Kennedy</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Thomson Medstat, Cambridge, Massachusetts</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Lenhart, Gregory" sort="Lenhart, Gregory" uniqKey="Lenhart G" first="Gregory" last="Lenhart">Gregory Lenhart</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Thomson Medstat, Cambridge, Massachusetts</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2005-11">2005-11</date><biblScope unit="vol">20</biblScope><biblScope unit="issue">11</biblScope><biblScope unit="page" from="1449">1449</biblScope><biblScope unit="page" to="1454">1454</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">D5F4BC3C405F04FCE02FD174DC18799BEDFB75ED</idno><idno type="DOI">10.1002/mds.20609</idno><idno type="ArticleID">MDS20609</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Age Factors</term><term>Aged</term><term>Aged, 80 and over</term><term>Child</term><term>Child, Preschool</term><term>Cohort Studies</term><term>Confidence Intervals</term><term>Cost of Illness</term><term>Costs</term><term>Databases, Factual (statistics & numerical data)</term><term>Female</term><term>Health Care Costs</term><term>Humans</term><term>Infant</term><term>Male</term><term>Middle Aged</term><term>Nervous system diseases</term><term>Parkinson Disease (economics)</term><term>Parkinson Disease (epidemiology)</term><term>Parkinson disease</term><term>Parkinson's disease</term><term>Prevalence</term><term>Retrospective Studies</term><term>Sex Factors</term><term>cost of illness</term><term>health economics</term><term>resource use</term></keywords><keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Databases, Factual</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Age Factors</term><term>Aged</term><term>Aged, 80 and over</term><term>Child</term><term>Child, Preschool</term><term>Cohort Studies</term><term>Confidence Intervals</term><term>Cost of Illness</term><term>Female</term><term>Health Care Costs</term><term>Humans</term><term>Infant</term><term>Male</term><term>Middle Aged</term><term>Prevalence</term><term>Retrospective Studies</term><term>Sex Factors</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Coût</term><term>Parkinson maladie</term><term>Système nerveux pathologie</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This study quantifies direct medical care costs for individual patients with Parkinson's disease (PD) and projects total national costs of PD. Anonymous, patient‐level data on health care utilization and cost were obtained from Medstat's MarketScan Research Databases. Patients were selected for study if they had either two instances of a diagnosis of PD or one diagnosis and two or more prescriptions for PD‐related medication. A control group of persons without PD was selected for comparison. Total annual health care utilization and costs were calculated for both PD patients and controls. A total of 20,016 patients with PD were identified and followed up for an average of 853 days. The mean age of the patients was 73.6 years, and 51.2% were women. Total annual direct costs were $23,101 (SD 27,529) per patient with PD versus $11,247 (SD 16,486) for controls. The regression‐adjusted incremental direct cost of PD versus control was $10,349 (95% confidence interval, 9,053, 11,645). Adding $25,326 in indirect costs, and multiplying by 645,000 cases of PD in the United States, the total cost to the nation is projected to be $23 billion annually. This estimate is higher than most previous studies, with important implications for health care delivery systems worldwide. © 2005 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Massachusetts</li><li>Missouri (État)</li></region></list><tree><country name="États-Unis"><region name="Massachusetts"><name sortKey="Huse, Daniel M" sort="Huse, Daniel M" uniqKey="Huse D" first="Daniel M." last="Huse">Daniel M. Huse</name></region><name sortKey="Castelli Aley, Jane" sort="Castelli Aley, Jane" uniqKey="Castelli Aley J" first="Jane" last="Castelli-Haley">Jane Castelli-Haley</name><name sortKey="Kennedy, Sean" sort="Kennedy, Sean" uniqKey="Kennedy S" first="Sean" last="Kennedy">Sean Kennedy</name><name sortKey="Lenhart, Gregory" sort="Lenhart, Gregory" uniqKey="Lenhart G" first="Gregory" last="Lenhart">Gregory Lenhart</name><name sortKey="Orsini, Lucinda" sort="Orsini, Lucinda" uniqKey="Orsini L" first="Lucinda" last="Orsini">Lucinda Orsini</name><name sortKey="Schulman, Kathy" sort="Schulman, Kathy" uniqKey="Schulman K" first="Kathy" last="Schulman">Kathy Schulman</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003997 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003997 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:D5F4BC3C405F04FCE02FD174DC18799BEDFB75ED
|texte= Burden of illness in Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |